Biomerica, Inc. (BMRA)
1.68
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
1.71
+0.03
(+1.79%)
After-Hours: 20:00
Biomerica EPS Diluted (Quarterly) : -0.3738 for Aug. 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2026 | -0.3738 |
| May 31, 2026 | -0.3729 |
| February 28, 2026 | -0.4358 |
| November 30, 2025 | -0.4539 |
| August 31, 2025 | 0.0008 |
| May 31, 2025 | -0.6064 |
| February 28, 2025 | -0.485 |
| November 30, 2024 | -0.4439 |
| August 31, 2024 | -0.0782 |
| May 31, 2024 | -0.0845 |
| February 29, 2024 | -0.114 |
| November 30, 2023 | -0.0896 |
| August 31, 2023 | -0.0673 |
| May 31, 2023 | -0.1065 |
| February 28, 2023 | -0.1224 |
| November 30, 2022 | -0.9668 |
| August 31, 2022 | -0.1582 |
| May 31, 2022 | -0.1367 |
| February 28, 2022 | -0.0081 |
| November 30, 2021 | -0.0894 |
| August 31, 2021 | -0.1241 |
| May 31, 2021 | -1.112 |
| February 28, 2021 | -1.428 |
| November 30, 2020 | -1.169 |
| August 31, 2020 | -1.289 |
| Date | Value |
|---|---|
| May 31, 2020 | -0.0426 |
| February 29, 2020 | -0.0877 |
| November 30, 2019 | -0.0494 |
| August 31, 2019 | -0.052 |
| May 31, 2019 | -0.0832 |
| February 28, 2019 | -0.0728 |
| November 30, 2018 | -0.0527 |
| August 31, 2018 | -0.05 |
| May 31, 2018 | -0.08 |
| February 28, 2018 | -0.04 |
| November 30, 2017 | -0.03 |
| August 31, 2017 | -0.02 |
| May 31, 2017 | -0.04 |
| February 28, 2017 | -0.04 |
| November 30, 2016 | -0.02 |
| August 31, 2016 | -0.01 |
| May 31, 2016 | -0.16 |
| February 29, 2016 | -0.02 |
| November 30, 2015 | -0.01 |
| August 31, 2015 | -0.01 |
| May 31, 2015 | 0.0321 |
| February 28, 2015 | -0.02 |
| November 30, 2014 | -0.03 |
| August 31, 2014 | -0.03 |
| May 31, 2014 | 0.0224 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5293 |
| Align Technology, Inc. | 1.514 |
| AngioDynamics, Inc. | -0.1689 |
| Accuray, Inc. | -0.0154 |
| Alphatec Holdings, Inc. | -0.1647 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.232M |
| Revenue (Quarterly) | 1.265M |
| Total Expenses (Quarterly) | 2.497M |
| Enterprise Value | 7.319M |
| Gross Profit Margin (Quarterly) | 8.14% |
| Profit Margin (Quarterly) | -97.39% |
| Earnings Yield | -97.40% |
| Normalized Earnings Yield | -101.95 |